title: Treatment for patients with Her2-Positive breast cancer may have ethnic-related adverse events.
authors.affiliation: Tongji University Cancer Institute, Tongji University School of Medicine, Shanghai 200092, China. Electronic address: beakham13@126.com.
authors.forename: Xiaoshen
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D000068878:Trastuzumab / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D000068878:Trastuzumab
keywords: Adverse events; Ethnicity; Her2-positive breast cancer